|
| 36529140 | Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-β signaling. | Cell Chem Biol | 2023 |
| 37509350 | Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity. | Cancers (Basel) | 2023 |
| 36519841 | Increased sensitivity to chemically induced colitis in mice harboring a DNA-binding deficient aryl hydrocarbon receptor. | Toxicol Sci | 2023 |
| 35055106 | Reduced Colonic Mucosal Injury in 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-Dioxin Poly ADP-Ribose Polymerase (TIPARP/PARP7)-Deficient Mice. | Int J Mol Sci | 2022 |
| 33475084 | Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targets. | Elife | 2021 |
| 34129049 | 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (TiparpH532A) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and Lethality. | Toxicol Sci | 2021 |
| 32763287 | The impact of sex on hepatotoxic, inflammatory and proliferative responses in mouse models of liver carcinogenesis. | Toxicology | 2020 |
| 33020065 | Cell Type-Specific Roles of CD38 in the Interactions of Isoniazid with NAD<sup>+</sup> in the Liver. | Drug Metab Dispos | 2020 |
| 31075357 | Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen. | Pharmacol Ther | 2019 |
| 30883722 | A readout of metabolic efficiency in arylamine N-acetyltransferase-deficient mice reveals minor energy metabolism changes. | FEBS Lett | 2019 |
| 31083300 | 3-Methylcholanthrene Induces Chylous Ascites in TCDD-Inducible Poly-ADP-Ribose Polymerase (<i>Tiparp</i>) Knockout Mice. | Int J Mol Sci | 2019 |
| 30373764 | Characterization of TCDD-inducible poly-ADP-ribose polymerase (TIPARP/ARTD14) catalytic activity. | Biochem J | 2018 |
| 29873790 | Hepatocyte-Specific Deletion of TIPARP, a Negative Regulator of the Aryl Hydrocarbon Receptor, Is Sufficient to Increase Sensitivity to Dioxin-Induced Wasting Syndrome. | Toxicol Sci | 2018 |
| 28888949 | Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver. | Biochem Pharmacol | 2017 |
| 28277663 | Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy. | J Med Chem | 2017 |
| 27746196 | Influence of sex and developmental stage on acute hepatotoxic and inflammatory responses to liver procarcinogens in the mouse. | Toxicology | 2016 |
| 25601990 | N-hydroxylation of 4-aminobiphenyl by CYP2E1 produces oxidative stress in a mouse model of chemically induced liver cancer. | Toxicol Sci | 2015 |
| 26192006 | Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. | Diabetes Technol Ther | 2015 |
| 25922528 | Relative Contributions of CYP1A2 and CYP2E1 to the Bioactivation and Clearance of 4-Aminobiphenyl in Adult Mice. | Drug Metab Dispos | 2015 |
| 25975270 | Loss of the Mono-ADP-ribosyltransferase, Tiparp, Increases Sensitivity to Dioxin-induced Steatohepatitis and Lethality. | J Biol Chem | 2015 |
| 24623063 | Paradoxical attenuation of autoimmune hepatitis by oral isoniazid in wild-type and N-acetyltransferase-deficient mice. | Drug Metab Dispos | 2014 |
| 23861064 | Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. | Development | 2013 |
| 24205029 | 5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion. | PLoS One | 2013 |
| 22193722 | Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice. | Cancer Lett | 2012 |
| 22508569 | Influence of arylamine N-acetyltransferase, sex, and age on 4-aminobiphenyl-induced in vivo mutant frequencies and spectra in mouse liver. | Environ Mol Mutagen | 2012 |
| 21317369 | Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice. | Drug Metab Dispos | 2011 |
| 19295529 | Pharmacogenetics of pharmacoecology: which route to personalized medicine? | Clin Pharmacol Ther | 2009 |
| 20444014 | The role of para-aminophenol in acetaminophen-induced methemoglobinemia in dogs and cats. | J Vet Pharmacol Ther | 2009 |
| 18334921 | Changes in consensus arylamine N-acetyltransferase gene nomenclature. | Pharmacogenet Genomics | 2008 |
| 18680466 | Structures of human arylamine N-acetyltransferases. | Curr Drug Metab | 2008 |
| 17403913 | Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse. | Drug Metab Dispos | 2007 |
| 17656365 | Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. | J Biol Chem | 2007 |
| 17339856 | The art and science of personalized medicine. | Clin Pharmacol Ther | 2007 |
| 16815960 | In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice. | Drug Metab Dispos | 2006 |
| 15226670 | Pharmacogenetics and the regulation of gene transcription. | Pharmacogenetics | 2004 |
| 15595973 | A simple test for acetylator phenotype using caffeine. 1984. | Br J Clin Pharmacol | 2004 |
| 12815173 | Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. | Mol Pharmacol | 2003 |
| 11207033 | Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects. | Pharmacogenetics | 2001 |
| 11368758 | Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop. | Biochem J | 2001 |
| 10746928 | Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. | Toxicol Sci | 2000 |
| 10862519 | Update on consensus arylamine N-acetyltransferase gene nomenclature. | Pharmacogenetics | 2000 |
| 10899814 | A SNPshot: pharmacogenetics and the future of drug therapy. | Trends Biotechnol | 2000 |
| 10971207 | Pharmacogenetics of the human arylamine N-acetyltransferases. | Pharmacology | 2000 |
| 11095579 | Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. | Drug Metab Dispos | 2000 |
| 10794727 | Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. | Biochem J | 2000 |
| 10495364 | Pharmacogenomics and the changing face of clinical pharmacology. | Can J Clin Pharmacol | 1999 |
| 9682272 | Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. | Pharmacogenetics | 1998 |
| 9566732 | Novel sulfotransferases cloned by RT-PCR: real proteins or PCR artifacts? | Chem Biol Interact | 1998 |
| 9511182 | Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. | Pharmacogenetics | 1998 |
| 9731717 | NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations. | Pharmacogenetics | 1998 |